SILVER SPRING, M.D. (ABC NEWS) -The Food and Drug Administration issued a warning about a rare and deadly cancer linked to breast implants.
The FDA has sent letters to health care providers including plastic surgeons, physicians, and oncologists to help them diagnose the disease early.
The FDA says since 2011, at least 457 women in the U.S. have been diagnosed with anaplastic large cell lymphoma. Nine of them have died.
“Roughly 11 million women in the world have breast implants, 300,000 implants are done every year in the U.S.,” said ABC News Chief Medical Correspondent Dr. Jennifer Ashton. “The FDA wants not just doctors and healthcare providers to know these symptoms but women also with implants. They tend to show up around three years after the implants are put in.”
According to the FDA, implants with textured surfaces are more closely linked to the cancer than those with smooth surfaces.
Women considering surgery should discuss the risks and benefits of different implant types with their physicians. Those who already have implants should look out for symptoms.
- Redness or swelling on one side
- Asymmetry — one side looking different than the other
- New lump or mass
The FDA says this is not breast cancer but a rare cancer associated with breast implants.
“We have to remember this type of cancer this rare type of lymphoma is seen with the gummy bear or textured implants which are actually used more often in reconstruction than cosmetic surgery but again the good news the treatment if a woman finds this and it’s detected, removal of the implant rarely will the woman need chemo or radiation,” said Ashton.
If you are concerned or suffer from any of these symptoms contact your doctor.